LA-Z-BOY INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LA-Z-BOY INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 29, 2023 | $2.35B | Jun 20, 2023 |
| FY2023 | Apr 30, 2022 | $2.36B | Jun 20, 2023 |
| FY2023 | Apr 24, 2021 | $1.73B | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | $1.70B | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | $1.75B | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | $1.58B | Jun 23, 2020 |
| FY2019 | Apr 29, 2017 | $1.52B | Jun 18, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $2.11B | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $2.05B | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | $2.35B | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | $2.36B | Jun 17, 2024 |
| FY2023 | Apr 24, 2021 | $1.73B | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | $1.70B | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | $1.75B | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | $1.58B | Jun 23, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Apr 28, 2018 | $1.58B | Jun 19, 2018 |
| FY2017 | Apr 29, 2017 | $1.52B | Jun 20, 2017 |
| FY2016 | Apr 30, 2016 | $1.53B | Jun 21, 2016 |
| FY2015 | Apr 25, 2015 | $1.43B | Jun 16, 2015 |
| FY2015 | Apr 26, 2014 | $1.36B | Jun 16, 2015 |
| FY2015 | Apr 27, 2013 | $1.27B | Jun 16, 2015 |
| FY2013 | Apr 28, 2012 | $1.23B | Jun 18, 2013 |
| FY2013 | Apr 30, 2011 | $1.19B | Jun 18, 2013 |
| FY2012 | Apr 24, 2010 | $1.18B | Jun 19, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $926.42M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $881.67M | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | $964.73M | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | $879.79M | Jun 17, 2024 |
| FY2023 | Apr 24, 2021 | $740.26M | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | $721.45M | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | $702.57M | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | $622.75M | Jun 23, 2020 |
| FY2019 | Apr 29, 2017 | $609.30M | Jun 18, 2019 |
| FY2018 | Apr 30, 2016 | $584.98M | Jun 19, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $99.56M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $122.63M | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | $150.66M | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | $150.02M | Jun 17, 2024 |
| FY2023 | Apr 24, 2021 | $106.46M | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | $77.47M | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | $68.57M | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | $80.87M | Jun 23, 2020 |
| FY2019 | Apr 29, 2017 | $85.92M | Jun 18, 2019 |
| FY2018 | Apr 30, 2016 | $79.25M | Jun 19, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $135.84M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $150.80M | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | $211.44M | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | $206.76M | Jun 17, 2024 |
| FY2023 | Apr 24, 2021 | $136.74M | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | $118.76M | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | $129.67M | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | $129.37M | Jun 23, 2020 |
| FY2019 | Apr 29, 2017 | $133.34M | Jun 18, 2019 |
| FY2018 | Apr 30, 2016 | $125.33M | Jun 19, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $9.90M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $9.60M | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | $9.10M | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | $9.00M | Jun 17, 2024 |
| FY2023 | Apr 24, 2021 | $7.60M | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | $10.80M | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | $9.10M | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | $7.90M | Jun 23, 2020 |
| FY2019 | Apr 29, 2017 | $8.00M | Jun 18, 2019 |
| FY2018 | Apr 30, 2016 | $6.30M | Jun 19, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $770.00M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $730.87M | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | $753.29M | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | $673.04M | Jun 17, 2024 |
| FY2023 | Apr 24, 2021 | $603.52M | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | $575.82M | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | $572.90M | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | $493.38M | Jun 23, 2020 |
| FY2019 | Apr 29, 2017 | $475.96M | Jun 18, 2019 |
| FY2018 | Apr 30, 2016 | $459.65M | Jun 19, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $187.27M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $158.13M | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | $205.17M | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | $79.00M | Jun 17, 2024 |
| FY2023 | Apr 24, 2021 | $309.92M | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | $164.24M | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | $150.75M | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | $115.75M | Jun 23, 2020 |
| FY2019 | Apr 29, 2017 | $147.99M | Jun 18, 2019 |
| FY2018 | Apr 30, 2016 | $114.51M | Jun 19, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $74.28M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $53.55M | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | $68.81M | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | $76.58M | Jun 17, 2024 |
| FY2023 | Apr 24, 2021 | $37.96M | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | $46.04M | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | $48.43M | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | $36.34M | Jun 23, 2020 |
| FY2019 | Apr 29, 2017 | $20.30M | Jun 18, 2019 |
| FY2018 | Apr 30, 2016 | $24.68M | Jun 19, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $1.92B | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $1.91B | Jun 17, 2025 |
| FY2024 | Apr 29, 2023 | $1.87B | Jun 17, 2024 |
| FY2023 | Apr 30, 2022 | $1.93B | Jun 20, 2023 |
| FY2022 | Apr 24, 2021 | $1.79B | Jun 21, 2022 |
| FY2021 | Apr 25, 2020 | $1.43B | Jun 15, 2021 |
| FY2020 | Apr 27, 2019 | $1.06B | Jun 23, 2020 |
| FY2019 | Apr 28, 2018 | $892.97M | Jun 18, 2019 |
| FY2019 | Apr 29, 2017 | $888.86M | Jun 18, 2019 |
| FY2018 | Apr 30, 2016 | $800.03M | Jun 19, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $1.02B | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $1.00B | Jun 17, 2025 |
| FY2024 | Apr 29, 2023 | $941.84M | Jun 17, 2024 |
| FY2023 | Apr 30, 2022 | $810.73M | Jun 20, 2023 |
| FY2022 | Apr 24, 2021 | $773.50M | Jun 21, 2022 |
| FY2021 | Apr 25, 2020 | $700.75M | Jun 15, 2021 |
| FY2020 | Apr 27, 2019 | $682.51M | Jun 23, 2020 |
| FY2019 | Apr 28, 2018 | $612.18M | Jun 18, 2019 |
| FY2018 | Apr 29, 2017 | $589.92M | Jun 19, 2018 |
| FY2017 | Apr 30, 2016 | $547.14M | Jun 20, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $205.59M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $214.45M | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | $205.01M | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | $194.60M | Jun 17, 2024 |
| FY2023 | Apr 24, 2021 | $175.81M | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | $161.02M | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | $185.87M | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | $75.25M | Jun 23, 2020 |
| FY2019 | Apr 29, 2017 | $74.25M | Jun 18, 2019 |
| FY2018 | Apr 30, 2016 | $37.19M | Jun 19, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $597.43M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $598.01M | Jun 17, 2025 |
| FY2024 | Apr 29, 2023 | $545.16M | Jun 17, 2024 |
| FY2023 | Apr 30, 2022 | $431.18M | Jun 20, 2023 |
| FY2022 | Apr 24, 2021 | $399.01M | Jun 21, 2022 |
| FY2021 | Apr 25, 2020 | $343.63M | Jun 15, 2021 |
| FY2020 | Apr 27, 2019 | $325.85M | Jun 23, 2020 |
| FY2019 | Apr 28, 2018 | $291.64M | Jun 18, 2019 |
| FY2018 | Apr 29, 2017 | $284.70M | Jun 19, 2018 |
| FY2017 | Apr 30, 2016 | $252.47M | Jun 20, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $328.45M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $341.10M | Jun 17, 2025 |
| FY2024 | Apr 29, 2023 | $343.37M | Jun 17, 2024 |
| FY2023 | Apr 30, 2022 | $245.59M | Jun 20, 2023 |
| FY2022 | Apr 24, 2021 | $391.21M | Jun 21, 2022 |
| FY2021 | Apr 25, 2020 | $261.55M | Jun 15, 2021 |
| FY2020 | Apr 27, 2019 | $129.82M | Jun 23, 2020 |
| FY2019 | Apr 28, 2018 | $134.52M | Jun 18, 2019 |
| FY2018 | Apr 29, 2017 | $141.86M | Jun 19, 2018 |
| FY2017 | Apr 30, 2016 | $112.36M | Jun 20, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Apr 26, 2014 | $7.77M | Jun 17, 2014 |
| FY2013 | Apr 27, 2013 | $8.09M | Jun 18, 2013 |
| FY2013 | Apr 28, 2012 | $9.76M | Jun 18, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | 2 | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | 2 | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | 3 | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | 3 | Jun 17, 2024 |
| FY2023 | Apr 24, 2021 | 2 | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | 1 | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | 1 | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | 1 | Jun 23, 2020 |
| FY2019 | Apr 29, 2017 | 1 | Jun 18, 2019 |
| FY2018 | Apr 30, 2016 | 1 | Jun 19, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | 2 | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | 2 | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | 3 | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | 3 | Jun 17, 2024 |
| FY2023 | Apr 24, 2021 | 2 | Jun 20, 2023 |
| FY2022 | Apr 25, 2020 | 1 | Jun 21, 2022 |
| FY2021 | Apr 27, 2019 | 1 | Jun 15, 2021 |
| FY2020 | Apr 28, 2018 | 1 | Jun 23, 2020 |
| FY2019 | Apr 29, 2017 | 1 | Jun 18, 2019 |
| FY2018 | Apr 30, 2016 | 1 | Jun 19, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | 41.16M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | 42.44M | Jun 17, 2025 |
| FY2024 | Apr 29, 2023 | 43.32M | Jun 17, 2024 |
| FY2023 | Apr 30, 2022 | 43.09M | Jun 20, 2023 |
| FY2022 | Apr 24, 2021 | 45.36M | Jun 21, 2022 |
| FY2021 | Apr 25, 2020 | 45.86M | Jun 15, 2021 |
| FY2020 | Apr 27, 2019 | 46.96M | Jun 23, 2020 |
| FY2019 | Apr 28, 2018 | 46.79M | Jun 18, 2019 |
| FY2018 | Apr 29, 2017 | 48.47M | Jun 19, 2018 |
| FY2017 | Apr 30, 2016 | 49.33M | Jun 20, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 26, 2025 | $34.96M | Jun 17, 2025 |
| FY2025 | Apr 27, 2024 | $32.67M | Jun 17, 2025 |
| FY2025 | Apr 29, 2023 | $29.87M | Jun 17, 2025 |
| FY2024 | Apr 30, 2022 | $27.72M | Jun 17, 2024 |